CNY 56.05
(-0.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.73 Billion CNY | 2.21% |
2022 | 4.92 Billion CNY | 35.03% |
2021 | 3.65 Billion CNY | 23.81% |
2020 | 2.94 Billion CNY | 23.2% |
2019 | 2.39 Billion CNY | 31.02% |
2018 | 1.82 Billion CNY | 22.99% |
2017 | 1.48 Billion CNY | 18.54% |
2016 | 1.25 Billion CNY | 6.07% |
2015 | 1.18 Billion CNY | 42.34% |
2014 | 829.83 Million CNY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.12 Billion CNY | 7.35% |
2024 Q3 | 1.14 Billion CNY | 47.54% |
2024 Q1 | 1.04 Billion CNY | -33.44% |
2023 FY | 5.03 Billion CNY | 2.21% |
2023 Q4 | 1.57 Billion CNY | 27.97% |
2023 Q3 | 1.23 Billion CNY | 18.08% |
2023 Q1 | 1.14 Billion CNY | -17.25% |
2023 Q2 | 1.04 Billion CNY | -8.53% |
2022 Q2 | 1.14 Billion CNY | 12.05% |
2022 FY | 4.92 Billion CNY | 35.03% |
2022 Q4 | 1.37 Billion CNY | -0.71% |
2022 Q3 | 1.38 Billion CNY | 21.52% |
2022 Q1 | 1.01 Billion CNY | -8.24% |
2021 Q4 | 1.11 Billion CNY | 23.68% |
2021 FY | 3.65 Billion CNY | 23.81% |
2021 Q3 | 898.51 Million CNY | 5.42% |
2021 Q2 | 852.35 Million CNY | 8.13% |
2021 Q1 | 788.27 Million CNY | -8.51% |
2020 Q2 | 765.32 Million CNY | 32.28% |
2020 Q1 | 578.58 Million CNY | -19.75% |
2020 FY | 2.94 Billion CNY | 23.2% |
2020 Q4 | 861.6 Million CNY | 15.98% |
2020 Q3 | 742.88 Million CNY | -2.93% |
2019 Q1 | 499.09 Million CNY | -10.56% |
2019 FY | 2.39 Billion CNY | 31.02% |
2019 Q4 | 720.94 Million CNY | 16.84% |
2019 Q3 | 617.01 Million CNY | 10.94% |
2019 Q2 | 556.16 Million CNY | 11.43% |
2018 Q3 | 529.48 Million CNY | 31.75% |
2018 Q1 | 337.27 Million CNY | -5.09% |
2018 Q2 | 401.88 Million CNY | 19.16% |
2018 FY | 1.82 Billion CNY | 22.99% |
2018 Q4 | 558.01 Million CNY | 5.39% |
2017 Q3 | 428.23 Million CNY | 38.37% |
2017 Q1 | 336.35 Million CNY | 0.0% |
2017 FY | 1.48 Billion CNY | 18.54% |
2017 Q4 | 355.35 Million CNY | -17.02% |
2017 Q2 | 309.47 Million CNY | -7.99% |
2016 FY | 1.25 Billion CNY | 6.07% |
2015 FY | 1.18 Billion CNY | 42.34% |
2014 FY | 829.83 Million CNY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Shanghai Runda Medical Technology Co., Ltd. | 1.78 Billion CNY | -165.557% |
Joinn Laboratories(China)Co.,Ltd. | 505.68 Million CNY | -837.279% |
Autobio Diagnostics Co., Ltd. | 1.52 Billion CNY | -210.666% |
Thalys Medical Technology Group Inc. | 570.05 Million CNY | -731.445% |
Guangzhou Kingmed Diagnostics Group Co., Ltd. | 2.35 Billion CNY | -101.234% |
Chemclin Diagnostics Co., Ltd. | 169.33 Million CNY | -2699.083% |